Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 17 is a processed pseudogene derived from the keratin 8 gene (KRT8), which encodes a type II intermediate filament protein involved in the structural integrity of epithelial cells[5][1][7]. Processed pseudogenes like KRT8P17 are generated by reverse transcription of mature mRNA and integration back into the genome, typically lacking regulatory elements and introns, which renders them nonfunctional. KRT8P17 is one of many keratin 8 pseudogenes found throughout the human genome; these processed pseudogenes do not code for proteins and are not associated with known physiological or pathological functions[1][5][7]. KRT8P17 is not recognized as a drug target, receptor, enzyme, transporter, or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 17 (KRT8P17).